Abstract P3-16-01: Immune characterization of inflammatory breast cancer and correlation to pathological complete response

Mapping Intimacies ◽

10.1158/1538-7445.sabcs16-p3-16-01 ◽

2017 ◽

Author(s):

SM Reddy ◽

JA Wargo ◽

A Reuben ◽

J Reuben ◽

W Woodward ◽

...

Keyword(s):

Breast Cancer ◽

Inflammatory Breast Cancer ◽

Pathological Complete Response ◽

Complete Response

Download Full-text

Abstract P3-05-08: Lymphoid and myeloid cell characterization of inflammatory breast cancer tumor microenvironment and correlation to pathological complete response

10.1158/1538-7445.sabcs17-p3-05-08 ◽

2018 ◽

Author(s):

SM Reddy ◽

A Reuben ◽

H Jiang ◽

J Roszik ◽

MT Tetzlaff ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Microenvironment ◽

Inflammatory Breast Cancer ◽

Pathological Complete Response ◽

Myeloid Cell ◽

Complete Response ◽

Cell Characterization ◽

Download Full-text

P1-14-02: Correlation of Circulating Tumor Cells (CTC) and Circulating Endothelial Cells (CEC) with Pathological Complete Response (pCR) during Neoadjuvant Chemotherapy (CT) Combined with Bevacizumab in HER2 Negative Inflammatory Breast Cancer (IBC): Ancillary Study of Phase II Trial BEVERLY 1.

10.1158/0008-5472.sabcs11-p1-14-02 ◽

2011 ◽

Author(s):

J-Y Pierga ◽

F-C Bidard ◽

F Andre ◽

T Petit ◽

F Dalenc ◽

...

Keyword(s):

Breast Cancer ◽

Endothelial Cells ◽

Neoadjuvant Chemotherapy ◽

Tumor Cells ◽

Inflammatory Breast Cancer ◽

Pathological Complete Response ◽

Phase Ii Trial ◽

Complete Response ◽

Circulating Endothelial Cells ◽

Ancillary Study

Download Full-text

Abstract P6-12-03: Predictors of poor clinical outcome among patients with inflammatory breast cancer (IBC) who did and did not achieve pathological complete response (pCR) after neoadjuvant systemic chemotherapy

10.1158/0008-5472.sabcs13-p6-12-03 ◽

2013 ◽

Author(s):

H Masuda ◽

M Chavez-Mac Gregor ◽

DD Liu ◽

RH Alvarez ◽

S Krishnamurthy ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Outcome ◽

Inflammatory Breast Cancer ◽

Systemic Chemotherapy ◽

Pathological Complete Response ◽

Complete Response ◽

Poor Clinical Outcome

Download Full-text

Abstract OT1-02-05: A single arm phase II study of adjuvant anti-PD1 (pembrolizumab) in combination with hormonal therapy in patients with hormone receptor (HR)-positive localized inflammatory breast cancer (IBC) who did not achieve a pathological complete response (pCR) to neoadjuvant chemotherapy

10.1158/1538-7445.sabcs17-ot1-02-05 ◽

2018 ◽

Author(s):

A Alexander ◽

J Willey ◽

H Sun ◽

CA Parker ◽

AN Marx ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Inflammatory Breast Cancer ◽

Hormonal Therapy ◽

Hormone Receptor ◽

Pathological Complete Response ◽

Phase Ii Study ◽

Complete Response

Download Full-text

Pathological complete response (pCR) is not a good marker for inflammatory breast cancer (IBC) patients to predict improved long-term survival after neoadjuvant chemotherapy (NT)

Annals of Oncology ◽

10.1093/annonc/mdv117.13 ◽

2015 ◽

Vol 26 ◽

pp. iii15

Author(s):

F. Fei ◽

L. Tang ◽

G. Di

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Inflammatory Breast Cancer ◽

Pathological Complete Response ◽

Complete Response ◽

Term Survival ◽

Long Term Survival ◽

Download Full-text

Circulating tumor cells (CTC) and pathological complete response (pCR) as independent prognostic factors in inflammatory breast cancer (IBC) in a pooled analysis of two multicentre phase II trials (BEVERLY 1 & 2) of neoadjuvant chemotherapy combined with bevacizumab.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.108 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 108-108 ◽

Author(s):

Jean-Yves Pierga ◽

Francois-Clement Bidard ◽

Aurelie Autret ◽

Thierry Petit ◽

Fabrice Andre ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Neoadjuvant Chemotherapy ◽

Tumor Cells ◽

Inflammatory Breast Cancer ◽

Pathological Complete Response ◽

Complete Response ◽

Pooled Analysis ◽

Phase Ii Trials ◽

Multicentre Phase

Download Full-text

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab

Annals of Oncology ◽

10.1093/annonc/mdw535 ◽

2017 ◽

Vol 28 (1) ◽

pp. 103-109 ◽

Author(s):

J.-Y. Pierga ◽

F.-C. Bidard ◽

A. Autret ◽

T. Petit ◽

F. Andre ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Neoadjuvant Chemotherapy ◽

Inflammatory Breast Cancer ◽

Pathological Complete Response ◽

Complete Response ◽

Pooled Analysis ◽

Circulating Tumour Cells ◽

Phase Ii Trials ◽

Multicentre Phase

Download Full-text

Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer

Magnetic Resonance Materials in Physics Biology and Medicine ◽

10.1007/s10334-021-00941-0 ◽

2021 ◽

Author(s):

Angeline Nemeth ◽

Pierre Chaudet ◽

Benjamin Leporq ◽

Pierre-Etienne Heudel ◽

Fanny Barabas ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Pathological Complete Response ◽

Complete Response ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Study of pathological complete response rates with neoadjuvant concurrent chemoradiation with paclitaxel in locally advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdz097.008 ◽

2019 ◽

Vol 30 ◽

pp. iii36

Author(s):

P. Iyer ◽

V. Radhakrishnan ◽

A. Balasubramanian ◽

V. Sridevi ◽

A. Krishnamurthy ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Pathological Complete Response ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Response Rates ◽

Complete Response ◽

Advanced Breast ◽

Concurrent Chemoradiation

Download Full-text

Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.07.091 ◽

2005 ◽

Vol 63 ◽

pp. S52 ◽

Author(s):

S.E. McGuire ◽

A.M. Gonzalez-Angulo ◽

S.L. Tucker ◽

R. Rouzier ◽

E.A. Strom ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Pathological Complete Response ◽

Complete Response ◽

Stage Iii ◽

Stage Iii Breast Cancer

Download Full-text